These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 26972723)

  • 1. Paediatric HIV infection: the potential for cure.
    Goulder PJ; Lewin SR; Leitman EM
    Nat Rev Immunol; 2016 Apr; 16(4):259-71. PubMed ID: 26972723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-retroviral therapy failure in HIV-1 infected pregnant women and its associated risk of HIV transmission.
    Bardeskar NS; Ahir-Bist SP; Mehta PR; Samant-Mavani P; Nanavati R; Mania-Pramanik J
    Arch Gynecol Obstet; 2020 Nov; 302(5):1229-1235. PubMed ID: 32803392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers.
    Bunders M; Thorne C; Newell ML;
    AIDS; 2005 Jul; 19(10):1071-9. PubMed ID: 15958839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review).
    de Ruiter A; Taylor GP; Clayden P; Dhar J; Gandhi K; Gilleece Y; Harding K; Hay P; Kennedy J; Low-Beer N; Lyall H; Palfreeman A; O'Shea S; Tookey P; Tosswill J; Welch S; Wilkins E;
    HIV Med; 2014 Sep; 15 Suppl 4():1-77. PubMed ID: 25604045
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants.
    Frederick T; Homans J; Spencer L; Kramer F; Stek A; Operskalski E; Kovacs A
    Clin Infect Dis; 2012 Sep; 55(6):877-84. PubMed ID: 22675157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1.
    Pinnetti C; Tintoni M; Ammassari A; Tamburrini E; Bernardi S; Liuzzi G; Scambia G; Perno CF; Floridia M; Antinori A; Cavaliere AF
    AIDS; 2015 Nov; 29(18):2534-7. PubMed ID: 26372490
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of perinatal HIV transmission during pregnancy.
    McGowan JP; Shah SS
    J Antimicrob Chemother; 2000 Nov; 46(5):657-68. PubMed ID: 11062184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected vertical transmission of HIV infection.
    Giacomet V; Viganò A; Erba P; Nannini P; Pisanelli S; Zanchetta N; Brambilla T; Ramponi G; Zuccotti GV
    Eur J Pediatr; 2014 Jan; 173(1):121-3. PubMed ID: 23652937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse fetal and infant outcomes among HIV-infected women who received either nonnucleoside reverse transcriptase inhibitor-based or protease inhibitor-based antiretroviral therapy for prevention of mother-to-child transmission.
    Masaba R; Borkowf CB; Girde S; Zeh C; Ndivo R; Nyang'au I; Achola K; Thomas TK; Lecher SL
    AIDS; 2018 Jul; 32(12):1625-1632. PubMed ID: 30001243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk.
    Martinez DR; Vandergrift N; Douglas AO; McGuire E; Bainbridge J; Nicely NI; Montefiori DC; Tomaras GD; Fouda GG; Permar SR
    J Virol; 2017 May; 91(9):. PubMed ID: 28202762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV infection and pregnancy. Improved therapy management for HIV infected pregnant patients].
    MMW Fortschr Med; 2016 Jun; 158 Suppl 1():36-7. PubMed ID: 27259887
    [No Abstract]   [Full Text] [Related]  

  • 15. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
    Mandelbrot L; Tubiana R; Le Chenadec J; Dollfus C; Faye A; Pannier E; Matheron S; Khuong MA; Garrait V; Reliquet V; Devidas A; Berrebi A; Allisy C; Elleau C; Arvieux C; Rouzioux C; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Dec; 61(11):1715-25. PubMed ID: 26197844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure.
    Berendam SJ; Nelson AN; Goswami R; Persaud D; Haigwood NL; Chahroudi A; Fouda GG; Permar SR
    Curr HIV/AIDS Rep; 2020 Jun; 17(3):237-248. PubMed ID: 32356090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi.
    Weigel R; Hosseinipour MC; Feldacker C; Gareta D; Tweya H; Chiwoko J; Gumulira J; Kalulu M; Mofolo I; Kamanga E; Mwale G; Kadzakumanja A; Jere E; Phiri S
    Trop Med Int Health; 2012 Jun; 17(6):751-9. PubMed ID: 22487553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of gender and pregnancy on antiretroviral therapy for HIV: pharmacokinetic and disease-related differences.
    Scarsi KK; Postelnick MJ
    J Gend Specif Med; 2003; 6(1):7-16. PubMed ID: 12661172
    [No Abstract]   [Full Text] [Related]  

  • 20. Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission.
    Klein N; Palma P; Luzuriaga K; Pahwa S; Nastouli E; Gibb DM; Rojo P; Borkowsky W; Bernardi S; Zangari P; Calvez V; Compagnucci A; Wahren B; Foster C; Munoz-Fernández MÁ; De Rossi A; Ananworanich J; Pillay D; Giaquinto C; Rossi P
    Lancet Infect Dis; 2015 Sep; 15(9):1108-1114. PubMed ID: 26187030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.